Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Variations in mitochondrial genome as potential prognostic markers in sickle cell disease.
Journal: Haematologica
Published: November 18, 2025
Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States.
Journal: Journal of medical economics
Published: January 19, 2021
Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease.
Journal: Blood
Published: September 09, 2020
Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy.
Journal: Journal of managed care & specialty pharmacy
Published: May 29, 2020
Electronic health record year and country of birth testing and patient navigation to increase diagnosis of chronic viral hepatitis.
Journal: Journal of viral hepatitis
Published: December 16, 2018
Showing 1-5 of 5
Last Updated: 09/26/2026